– Event organized by IVI to discuss ways of cooperation to help increase Korea’s vaccine self-sufficiency, and accelerate globalization of the Korean vaccine industry
Key participants pose for a commemorative photo at the ‘IVI Forum for Enhancement of Cooperation’ at the National Assembly of the Republic of Korea on March 26, 2019.
From left: Dr. BG Rhee, Chairman of the Korea Support Committee (KSC) for IVI’s Board of Trustees; IVI Director General Dr. Jerome Kim; H.E. Mr. Jakob Hallgren, Swedish Ambassador to Korea; Rep. Choi Do-ja; Prof. Cho Wan-kyoo, Executive Advisor to KSC; Rep. Rep. Lee Myung-soo, Chair of the Parliamentary Health and Welfare Committee; H.E. Ms. Sripriya Ranganathan, Indian Ambassador to Korea; Dr. Jeong Eun-kyeong, Director of KCDC; Rep. Oh Je-se; and Dr. Julia Lynch, Deputy Director General of Development and Delivery, and Mr. Francois Belin, COO of IVI.
SEOUL, Korea — A forum took place with the view to accelerate cooperation in vaccine research and development between the Republic of Korea and the International Vaccine Institute (IVI), the first international organization headquartered in Korea, at the Korean National Assembly in Seoul on March 26.
The event was hosted jointly by the Korean Parliamentary Forum for Global Health and the Korea Center for Disease Control and Prevention (KCDC) under the Ministry of Health and Welfare. The forum was aimed at accelerating the globalization of the Korean vaccine industry and expanding Korea’s contributions to global health.
Approximately 50 participants gathered at the National Assembly Members’ Office Building. Among those in attendance were: Rep. Lee Myung-soo, Chair of the Parliamentary Health and Welfare Committee, committee members Rep. Choi Do-ja, and Rep. Oh Je-se, IVI Director General Dr. Jerome Kim; as well as the Swedish Ambassador to Korea, H.E. Mr. Jakob Hallgren, and the Indian Ambassador to Korea, H.E. Ms. Sripriya Ranganathan.
The event also brought together officials from the Ministry of Health and Welfare, KCDC, the Ministry of Foreign Affairs, the Ministry of Food and Drug Safety, and KOICA; as well as experts from industry, academia and research institutes. The participants held discussions to determine the government ministries’ needs and to explore ways of cooperation with IVI in the field of international health and across the global vaccine network.
Rep. Lee Myung-soo, Chair of the Parliamentary Health and Welfare Committee, delivers the opening speech at the ‘IVI Forum for Enhancement of Cooperation.’
“As the host to IVI – the world’s only international organization devoted to vaccine research and development, Korea is well positioned in the global effort in vaccine R&D for global health. Our government, industry, and academia sectors will need to closely cooperate with IVI, and make most of IVI’s global network, experience and capabilities in vaccine development in order to accelerate the globalization of the Korean vaccine industry,” Rep. Lee Myung-soo said in his opening remarks.
Dr. Jeong Eun-kyeong, Director of KCDC, delivers her congratulatory remarks at the ‘IVI Forum for Enhancement of Cooperation.’
KCDC Director Dr. Jeong Eun-kyeong said that in order for Korea to expedite vaccine research and development, not only cooperation between government ministries and between industry, academia and research institutes, but cooperation with international organizations is also important. “IVI, which the Korean government has been supporting, has made achievements in vaccine research collaboration, clinical trials overseas, human resource development, and establishment of a global R&D partnership,” Dr. Jeong said. “Going forward, we hope that IVI continues endeavors to play a key role in global vaccine research, thereby carrying out its mandate as an international organization dedicated to developing vaccines for developing countries and humanity.”
The Swedish Ambassador to Korea, H.E. Mr. Jakob Hallgren, delivers a congratulatory speech introducing a decades-long partnership between Sweden and IVI.
The Indian Ambassador to Korea, H.E. Ms. Sripriya Ranganathan, gives a congratulatory speech.
IVI Director General Dr. Jerome Kim gives a talk entitled “Introduction to IVI and IVI’s Major Achievements.”
“The Republic of Korea has been making tremendous contributions to improving global health by hosting and supporting IVI. The Korean government has been stepping up efforts to increase vaccine self-sufficiency in recent years, but Korea alone, with a population of some 50 million people, is rather small for a vaccine market. As such, Korean vaccine self-sufficiency will necessarily lead to export into the global market and Korean vaccine companies will then be able to grow and thrive,” said Dr. Jerome Kim, Director General of IVI.
Dr. Kim went on to say that, “IVI has a collaborative network with more than 160 partners worldwide within areas ranging from government, industry, and academia, to civil society and intergovernmental organizations; and operates research programs in over 30 countries worldwide. We have worked extensively in public-private partnerships and this experience was invaluable when IVI was asked by MOHW to help in the creation of the Research Investment in Global Health Technology (RIGHT) fund, a public private partnership funded by the Korean Government, the Bill and Melinda Gates Foundation, and 5 Korean vaccine companies, an innovative funding approach to the development of vaccines, drugs and diagnostics for Global Health.”
Some of the participants pose together in a group photo session.
The IVI Forum for Enhancement of Cooperation is in session.
Prof. Ray Cho (center), Emeritus Professor of Yonsei University, chairs the roundtable session.
After the initial IVI introduction and capabilities overview in Session 1, the forum proceeded with Roundtable Meetings in Session 2, which included three panel meetings regarding methods of cooperation between IVI and the government (MOHW, KCDC, MOFA, and MFDS), public organizations (KOICA, KHIDI, etc.), and academic institutions to enable IVI to take a more active role in increasing Korea’s vaccine self-sufficiency and the globalization of its vaccine industry.
About the International Vaccine Institute
The International Vaccine Institute (IVI) is the world’s only international organization devoted exclusively to discovery, development and delivery of safe, effective and affordable vaccines for global public health. Established in 1997, IVI operates as an independent international organization under a treaty signed by 35 countries and the World Health Organization. The Institute conducts research in more than 30 countries throughout Asia, Africa and Latin America on vaccines against diarrheal infections, bacterial meningitis and pneumonia, as well as Japanese encephalitis and dengue fever, and develops new and improved vaccines at its headquarters in Seoul, Republic of Korea. For more information, please visit www.ivi.int
Felicia An, Head of Communications, IVI
+82 2 881 1309 | Felicia.An@ivi.int
Tae Kyung Byun, Senior Manager of Korean Communications, IVI
+82 2 881 1159 | email@example.com